#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	13586	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2136	632.8	1	SNP	n	C1184T	0	.	.	1184	1184	C	1427	1427	C	823	C,G	767,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	24494	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3561	686.1	0	.	n	.	0	T695C	SNP	695	695	T	1047	1047	C	740	C	691	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	24494	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3561	686.1	0	.	n	.	0	G1337A	SNP	1337	1337	G	1689	1689	A	818	A,T	764,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	24494	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3561	686.1	0	.	n	.	0	T1971C	SNP	1971	1971	T	2323	2323	C	805	C,T	746,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	24494	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3561	686.1	1	SNP	n	A2045G	0	.	.	2045	2045	A	2397	2397	A	779	A	728	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	24494	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3561	686.1	1	SNP	n	C2597T	0	.	.	2597	2597	C	2949	2949	C	725	C	684	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1562	folP	858	858	91.61	folP.l15.c4.ctg.1	1592	98.0	0	.	p	.	0	V36A	NONSYN	106	108	GTG	439	441	GCG	171;169;170	G;C;G	160;157;158	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1562	folP	858	858	91.61	folP.l15.c4.ctg.1	1592	98.0	0	.	p	.	0	Q50R	NONSYN	148	150	CAG	481	483	CGG	174;173;173	C;G;G	163;160;159	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1562	folP	858	858	91.61	folP.l15.c4.ctg.1	1592	98.0	0	.	p	.	0	S68L	NONSYN	202	204	TCG	535	537	TTG	185;180;181	T;T;G	166;165;165	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1562	folP	858	858	91.61	folP.l15.c4.ctg.1	1592	98.0	0	.	p	.	0	A90V	NONSYN	268	270	GCG	601	603	GTT	170;172;170	G;T;T	154;147;152	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1562	folP	858	858	91.61	folP.l15.c4.ctg.1	1592	98.0	0	.	p	.	0	I105V	NONSYN	313	315	ATT	646	648	GTT	150;145;146	G;T;T	141;133;137	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1562	folP	858	858	91.61	folP.l15.c4.ctg.1	1592	98.0	0	.	p	.	0	N125T	NONSYN	373	375	AAT	706	708	ACC	157;155;153	A;C;C	144;144;146	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1562	folP	858	858	91.61	folP.l15.c4.ctg.1	1592	98.0	0	.	p	.	0	R135C	NONSYN	403	405	CGT	736	738	TGT	170;170;167	T;G;T	151;154;149	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1562	folP	858	858	91.61	folP.l15.c4.ctg.1	1592	98.0	0	.	p	.	0	K151E	NONSYN	451	453	AAA	784	786	GAA	136;134;132	G;A;A	120;118;119	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1562	folP	858	858	91.61	folP.l15.c4.ctg.1	1592	98.0	0	.	p	.	0	T152N	NONSYN	454	456	ACC	787	789	AAC	130;129;132	A;A;C	115;117;120	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1562	folP	858	858	91.61	folP.l15.c4.ctg.1	1592	98.0	0	.	p	.	0	A172T	NONSYN	514	516	GCG	847	849	ACA	116;114;116	A;C;A	110;108;110	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1562	folP	858	858	91.61	folP.l15.c4.ctg.1	1592	98.0	0	.	p	.	0	A175E	NONSYN	523	525	GCG	856	858	GAA	121;123;127	G;A;A	117;118;122	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1562	folP	858	858	91.61	folP.l15.c4.ctg.1	1592	98.0	0	.	p	.	0	E176T	NONSYN	526	528	GAA	859	861	ACC	128;132;133	A;C;C	121;125;126	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1562	folP	858	858	91.61	folP.l15.c4.ctg.1	1592	98.0	0	.	p	.	0	I178V	NONSYN	532	534	ATC	865	867	GTC	136;136;135	G;T;C	129;126;128	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1562	folP	858	858	91.61	folP.l15.c4.ctg.1	1592	98.0	0	.	p	.	0	I188T	NONSYN	562	564	ATA	895	897	ACG	151;153;150	A;C;G	137;142;138	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1562	folP	858	858	91.61	folP.l15.c4.ctg.1	1592	98.0	0	.	p	.	0	P200N	NONSYN	598	600	CCC	931	933	AAC	145;146;148	A;A;C	139;138;142	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1562	folP	858	858	91.61	folP.l15.c4.ctg.1	1592	98.0	0	.	p	.	0	F220L	NONSYN	658	660	TTT	991	993	TTG	159;158;164	T;T;G	146;143;149	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1562	folP	858	858	91.61	folP.l15.c4.ctg.1	1592	98.0	0	.	p	.	0	A239T	NONSYN	715	717	GCA	1048	1050	ACC	164;165;169	A;C;C	154;157;158	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1562	folP	858	858	91.61	folP.l15.c4.ctg.1	1592	98.0	0	.	p	.	0	N240D	NONSYN	718	720	AAT	1051	1053	GAC	169;170;170	G;A;C	159;153;156	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1562	folP	858	858	91.61	folP.l15.c4.ctg.1	1592	98.0	0	.	p	.	0	E243A	NONSYN	727	729	GAA	1060	1062	GCG	169;168;169	G;C;G	153;131;154	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1562	folP	858	858	91.61	folP.l15.c4.ctg.1	1592	98.0	0	.	p	.	0	S255A	NONSYN	763	765	TCC	1096	1098	GCT	134;132;135	G;C;T	119;116;117	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1562	folP	858	858	91.61	folP.l15.c4.ctg.1	1592	98.0	1	SNP	p	R230S	1	.	.	688	690	AGC	1021	1023	AGC	180;181;181	A;G;C	164;162;162	folP.Neisseria_meningitidis_MC58_v2_01707:1:1:R230S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5042	gyrA	2751	2751	99.85	gyrA.l15.c17.ctg.1	3416	147.2	1	SNP	p	S91F	0	.	.	271	273	TCC	616	618	TCC	183;183;186	T;C;C	165;166;167	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5042	gyrA	2751	2751	99.85	gyrA.l15.c17.ctg.1	3416	147.2	1	SNP	p	D95N	0	.	.	283	285	GAC	628	630	GAC	184;183;182	G;A;C	164;162;163	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5042	gyrA	2751	2751	99.85	gyrA.l15.c17.ctg.1	3416	147.2	1	SNP	p	D95G	0	.	.	283	285	GAC	628	630	GAC	184;183;182	G;A;C	164;162;163	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_W_01449	mtrR.WHO_W_01449	1	1	27	1674	mtrR	633	633	100.0	mtrR.l15.c30.ctg.1	1380	120.8	1	SNP	p	G45D	1	.	.	133	135	GAC	499	501	GAC	217;217;218	G;A,G;C	202;199,1;201	mtrR.WHO_W_01449:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	856	mtrR_promoter	250	250	100.0	mtrR_promoter.l6.c17.ctg.1	928	91.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	4944	parC	2304	2304	100.0	parC.l15.c17.ctg.1	2821	174.2	1	SNP	p	D86N	0	.	.	256	258	GAC	547	549	GAC	200;200;198	G;A;C	193;188;188	parC.WHO_P_00203c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	4944	parC	2304	2304	100.0	parC.l15.c17.ctg.1	2821	174.2	1	SNP	p	S87I	0	.	.	259	261	AGT	550	552	AGT	200;198;200	A;G;T	190;190;192	parC.WHO_P_00203c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	4944	parC	2304	2304	100.0	parC.l15.c17.ctg.1	2821	174.2	1	SNP	p	S87R	0	.	.	259	261	AGT	550	552	AGT	200;198;200	A;G;T	190;190;192	parC.WHO_P_00203c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	4944	parC	2304	2304	100.0	parC.l15.c17.ctg.1	2821	174.2	1	SNP	p	S87W	0	.	.	259	261	AGT	550	552	AGT	200;198;200	A;G;T	190;190;192	parC.WHO_P_00203c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	4944	parC	2304	2304	100.0	parC.l15.c17.ctg.1	2821	174.2	1	SNP	p	S88P	0	.	.	262	264	TCC	553	555	TCC	198;200;200	T;C;C	190;191;192	parC.WHO_P_00203c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4146	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2578	160.2	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1549	1551	GGC	202;201;202	G;G;C	192;190;191	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.2.001	penA.2.001	1	1	27	3532	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2309	152.2	1	SNP	p	A311V	0	.	.	931	933	GCA	1202	1204	GCA	182;183;183	G;C;A,C	166;168;167,1	penA.2.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3532	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2309	152.2	1	SNP	p	I312M	0	.	.	934	936	ATC	1205	1207	ATC	186;186;187	A;T;C,G	170;169;168,1	penA.2.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3532	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2309	152.2	1	SNP	p	V316T	0	.	.	946	948	GTG	1217	1219	GTG	181;182;182	G,A;T,C;G,A,C	163,1;164,1;163,1,1	penA.2.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3532	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2309	152.2	1	SNP	p	V316P	0	.	.	946	948	GTG	1217	1219	GTG	181;182;182	G,A;T,C;G,A,C	163,1;164,1;163,1,1	penA.2.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3532	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2309	152.2	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1721	1723	ACC	181;179;176	A;C;C	162;163;160	penA.2.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3532	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2309	152.2	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1775	1777	GCG	164;165;163	G;C;G	147;135;135	penA.2.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3532	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2309	152.2	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1775	1777	GCG	164;165;163	G;C;G	147;135;135	penA.2.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3532	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2309	152.2	1	SNP	p	G543S	0	.	.	1627	1629	GGC	1898	1900	GGC	189;185;185	G;G;C	169;168;165	penA.2.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3532	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2309	152.2	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1907	1909	GGC	177;176;176	G;G;C	157;158;160	penA.2.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3532	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2309	152.2	1	SNP	p	P552S	0	.	.	1654	1656	CCG	1925	1927	CCG	145;146;147	C,CGGG;C;GCCC,GGCCCCC	110,1;111;106,1	penA.2.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	27	5182	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	3032	170.3	1	SNP	p	L421P	0	.	.	1261	1263	CTG	1561	1563	CTG	194;195;193	C;T;G	172;171;170	ponA.WHO_F_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2128	porA	1146	1146	99.83	porA.l15.c4.ctg.1	1769	119.4	0	.	p	.	0	M83fs	FSHIFT	247	247	A	488	488	C	150	C	132	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2390	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1471	161.5	0	.	p	.	0	G38E	NONSYN	112	114	GGA	402	404	GAA	195;197;194	G;A;A	176;179;177	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2390	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1471	161.5	0	.	p	.	0	R40Q	NONSYN	118	120	CGG	408	410	CAG	194;193;195	C;A;G	176;177;180	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2390	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1471	161.5	0	.	p	.	0	S46G	NONSYN	136	138	AGC	426	428	GGC	192;193;192	G;G;C	180;181;178	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2390	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1471	161.5	0	.	p	.	0	E48G	NONSYN	142	144	GAA	432	434	GGA	192;191;193	G;G;A	178;178;179	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2390	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1471	161.5	0	.	p	.	0	T87A	NONSYN	259	261	ACT	549	551	GCT	174;177;181	G;C;T	161;162;162	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2390	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1471	161.5	0	.	p	.	0	T89S	NONSYN	265	267	ACC	555	557	AGC	181;179;178	A,G;G;C	165,1;167;165	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2390	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1471	161.5	0	.	p	.	0	.	MULTIPLE	358	359	AA	647	648	CG	200;201	C;G	191;191	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2390	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1471	161.5	0	.	p	.	0	.	MULTIPLE	361	362	GA	650	652	CAG	198;195;196	C;A;G	187;185;185	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2390	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1471	161.5	0	.	p	.	0	N122K	NONSYN	364	366	AAC	654	656	AAA	200;201;201	A;A;A	192;192;189	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2390	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1471	161.5	0	.	p	.	0	K143E	NONSYN	427	429	AAA	717	719	GAA	183;186;187	G;A;A	176;180;179	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2390	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1471	161.5	0	.	p	.	0	V151A	NONSYN	451	453	GTA	741	743	GCA	197;197;199	G;C;A	185;183;183	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2390	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1471	161.5	0	.	p	.	0	A215T	NONSYN	643	645	GCT	933	935	ACT	200;203;201	A;C;T	186;188;187	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2390	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1471	161.5	0	.	p	.	0	I218M	NONSYN	652	654	ATA	942	944	ATG	205;207;207	A;T;G	196;197;197	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2390	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1471	161.5	0	.	p	.	0	T256A	NONSYN	766	768	ACA	1056	1058	GCA	173;173;172	G;C;A	167;169;168	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2390	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1471	161.5	0	.	p	.	0	W257T	NONSYN	769	771	TGG	1059	1061	ACG	171;172;174	A;C;G	166;167;168	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2390	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1471	161.5	0	.	p	.	0	S258R	NONSYN	772	774	AGT	1062	1064	AGG	179;178;177	A;G;G	174;171;170	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2390	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1471	161.5	0	.	p	.	0	A259V	NONSYN	775	777	GCT	1065	1067	GTT	179;179;179	G;T;T	171;169;172	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2390	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1471	161.5	0	.	p	.	0	L279V	NONSYN	835	837	TTA	1125	1127	GTA	221;223;225	G;T;A	208;208;210	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2390	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1471	161.5	0	.	p	.	0	S292T	NONSYN	874	876	TCT	1164	1166	ACT	232;233;235	A;C,T;T,G	213;217,1;217,1	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2390	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1471	161.5	0	.	p	.	0	H294D	NONSYN	880	882	CAT	1170	1172	GAT	238;238;241	G;A;T	222;222;226	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2390	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1471	161.5	0	.	p	.	0	Y298H	NONSYN	892	894	TAC	1182	1184	CAC	227;225;229	C;A;C	209;207;213	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2390	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1471	161.5	1	SNP	p	G120K	1	.	.	358	360	AAG	647	649	CGG	200;201;200	C;G;G	191;191;190	porB1b.WHO_L_01891c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2390	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1471	161.5	1	SNP	p	A121D	1	.	.	361	363	GAC	650	653	CGC	198;196;199	C;G;C	187;185;190	porB1b.WHO_L_01891c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2390	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1471	161.5	1	SNP	p	D121N	0	.	.	361	363	GAC	650	653	CGC	198;196;199	C;G;C	187;185;190	porB1b.WHO_L_01891c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	27	9480	rpoB	4179	4179	100.0	rpoB.l15.c4.ctg.1	4895	193.3	1	SNP	p	H553N	0	.	.	1657	1659	CAT	2030	2032	CAT	205;205;204	C;A;T	195;195;193	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	944	rpsJ	312	312	100.0	rpsJ.l15.c30.ctg.1	1125	83.5	1	SNP	p	V57M	1	.	.	169	171	ATG	593	595	ATG	174;174;174	A;T;G,T	163;162;157,1	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
